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in Mitotic-Spindle Checkpoint
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1Department of Radiation Biology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima; and 2Division of
Genetics, Medical Research Institute, Tokyo Medical and Dental University, and 3Hachioji, Tokyo
Skin fibroblast cells from two unrelated male infants with a chromosome-instability disorder were analyzed for
their response to colcemid-induced mitotic-spindle checkpoint. The infants both had severe growth and develop-
mental retardation, microcephaly, and Dandy-Walker anomaly; developed Wilms tumor; and one died at age 5 mo,
the other at age 3 years. Their metaphases had total premature chromatid separation (total PCS) and mosaic
variegated aneuploidy. Mitotic-index analysis of their cells showed the absence of mitotic block after the treatment
with colcemid, a mitotic-spindle inhibitor. Bromodeoxyuridine-incorporationmeasurement andmicroscopic analysis
indicated that cells treated with colcemid entered G1 and S phases without sister-chromatid segregation and cy-
tokinesis. Preparations of short-term colcemid-treated cells contained those cells with chromosomes in total PCS
and all or clusters of them encapsulated by nuclear membranes. Cell-cycle studies demonstrated the accumulation
of cells with a DNA content of 8C. These findings indicate that the infants’ cells were insensitive to the colcemid-
induced mitotic-spindle checkpoint.
We (Kajii et al. 1998) recently reported a chromosom-
al instability syndrome in two infants, characterized by
(1) premature separation of chromatids (PCS [MIM
176430]) in all chromosomes, called “total premature
chromatid separation” (total PCS), in 150% of their
lymphocytes, and (2) a variety of mosaic aneuploidies,
especially trisomies, double trisomies, and monosomies,
a finding called “mosaic variegated aneuploidy.” The
clinical findings in these two infants included severe pre-
and postnatal growth retardation, profound develop-
mental retardation, severe microcephaly, hypodysplasia
of the brain, Dandy-Walker anomaly, bilateral cataracts,
and uncontrollable clonic seizures. One of them devel-
oped Wilms tumor, and both died at age !2 years. In
the two families, the parents and three other relatives
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showed 2.5%–47% of lymphocytes with total PCS but
without either mosaic variegated aneuploidy or phe-
notypic abnormalities. The total-PCS trait thus was
transmitted in an autosomal dominant fashion, and the
two affected infants were homozygous for the trait. The
clinical findings for the disorder, on the other hand, ap-
pear to be autosomal recessive. We reasoned that, in
view of the presence of chromosomal instability in the
somatic cells of the affected infants, the basis of the
chromosomal instability disorder that we had described
might be a mitotic-spindle checkpoint defect, similar to
those in the colorectal cancer cells described by Cahill
et al. (1998).
We established skin fibroblast cell lines from another
two unrelated Japanese infants with the homozygous
total-PCS trait—cell line MY1sk from a male infant (pa-
tient 1) who had not previously been reported and cell
line PCS1 from a male infant (patient 2) reported by
Kawame et al. (1999). These two infants both had severe
pre- and postnatal growth retardation, profound devel-
opmental retardation, severe microcephaly, hypodyspla-
sia of the brain, Dandy-Walker anomaly, and hypoplasia
of the corpus callosum. Patient 2, in addition, had bi-
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Figure 1 A, top, Giemsa-staining of normal fibroblasts (TIG-
3) 24 h after treatment with 1 mg of colcemid/ml. Cells with tightly
condensed chromosomes characteristic of longstanding mitotic arrest
are indicated (arrows). A, middle, Cells from patient 1 (MY1sk),
treated in the same manner and including multinucleated cells (arrow-
heads) but without those with mitotic figures. A, bottom, Cell from
patient 2 (PCS1), with multiple small nuclei (arrowhead). B, Mitotic
indices after treatment with colcemid. Normal fibroblasts (TIG-3) and
a colorectal cancer cell line with microsatellite instability (HCT116)
both showed mitotic block, with a peak at 24 h of treatment with
colcemid; on the other hand, the cell lines from the two infants de-
scribed in the present report (MY1sk and PCS1) showed no appreciable
increase of mitotic cells with increasing duration of treatment with
colcemid. Caco2, a colorectal cancer cell line with well-demonstrated
chromosomal instability (Cahill et al. 1998), behaved in a similar
manner.
lateral cataracts with corneal opacities, hypospadias,
and bilateral cryptorchidism. Both of these infants de-
veloped intractable clonic seizures—patient 1 at age 4
mo, patient 2 at age 1 wk. Patient 1 developed a right-
kidney tumor at age 9 wk and underwent right nephrec-
tomy. Pathological examination showed stage I Wilms
tumor with favorable histology. Patient 2 developed, at
age 7 mo, bilateral cystic kidney tumors. Left nephrec-
tomy and right-tumor excision were performed, with a
resulting diagnosis of Wilms tumor (nephroblastoma
type). The two infants had 48.5%–87.5% of their lym-
phocytes, and 48%–50% of their cultured skin fibro-
blasts, in total PCS and had mosaic variegated aneu-
ploidy in both lymphocytes and cultured skin fibroblasts.
One died at age 5 mo, the other at age 3 years. Their
four phenotypically normal parents had 3.5%–42.5%
lymphocytes in total PCS but no mosaic variegated
aneuploidy.
Using these and reference cell lines, we analyzed their
cell cycle, according to the method described by Cahill
et al. (1998). In brief, cells were grown on a glass slide,
treated with 1 mg of colcemid/ml (a microtubule-dis-
rupting agent), harvested at 6-h intervals, fixed with 3:
1 methanol:acetic acid, stained with Hoechst 33258, and
analyzed under a fluorescence microscope. TIG-3 (nor-
mal fibroblasts) and HCT116 (a colorectal cancer cell
line with microsatellite instability) both accumulated mi-
totic cells, with a peak at 24 h after treatment with
colcemid (fig. 1A and B), an indication that these cells
have intact mitotic checkpoints. On the other hand,
MY1sk and PCS1 (fibroblast cell lines from the two
infants that we have described above) both showed an
abnormal response, with fewer mitotic cells and no clear
peak in mitotic index (fig. 1B). Instead, cells with mul-
tiple small nuclei appeared (fig. 1A) and accumulated,
accounting for 27.0%–27.9% of the cells after 24 h of
treatment with colcemid. Caco2 (a colorectal cancer cell
line with chromosomal instability) showed a response
of mitotic indices that was similar to that of MY1sk and
PCS1.
Chromosome preparations from MY1sk and PCS1,
treated with 0.2 mg of colcemid/ml for 3.5 h, had, re-
spectively, 65% and 55% metaphases in total PCS (fig.
2A), whereas those from Caco2 had no such cells. Of
the cells in total PCS, 25%–27% showed all or clusters
of chromosomes tightly packed and covered by nuclear
membranes (fig. 2B and C). These abnormal cells were
interpreted to have escaped mitotic arrest by colcemid
and to have entered telophase without going through
sister-chromatid segregation.
DNA synthesis in these cell lines was studied using
bromodeoxyuridine (BrdU) incorporation into replicat-
ing chromosomes as an indicator. In brief, cells were
grown on a glass slide and were treated with 1 mg of
colcemid/ml for 24 h, and BrdU was added at 10 mM 2
h prior to harvest. Cells were fixed with cold methanol
for 10 min, air-dried onto a glass slide, immersed in 2
M HCl at 37C for 1 h, neutralized with 0.1 M borate
buffer pH 8.5 for 10 min, washed three times with PBS,
and treated in a humidified chamber with 50 mg anti-
BrdU antibody conjugated with fluorescein/ml for 1 h.
The slides thus treated were washed three times with
PBS, counterstained with Hoechst 33258, and screened
under a fluorescence microscope. BrdU incorporation in
normal fibroblasts (TIG-3) after 24 h of treatment with
colcemid was reduced by 65% of the level seen in the
absence of treatment with colcemid. On the other hand,
BrdU incorporation in the fibroblast cells from the two
infants that we have described above (MY1sk and PCS1)
did not show appreciable decreases after treatment with
colcemid (data not shown). These results indicate that
the fibroblast cells from the two infants escaped mitotic
arrest and reentered S phase.
Flow-cytometric analysis was performed as described
elsewhere (Ito et al. 1999), to learn about cell-cycle pro-
files in these cell lines. In brief, cells were treated with
1 mg of colcemid/ml for 65 h, fixed with 70% cold eth-
anol, stained with 50 mg of propidium iodide/ml PBS,
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Figure 2 A, Metaphase in total PCS from skin fibroblasts (MY1sk) of patient 1, treated with 0.2 mg of colcemid/ml for 3.5 h. B, Another
cell from the same preparation, with two groups of chromosomes in total PCS, covered by nuclear membranes and in the process of formation
of micronuclei. C, Metaphase from skin fibroblasts (PCS1) of patient 2, with three groups of chromosomes encapsulated by nuclear membranes.
Figure 3 Flow-cytometric analysis of normal fibroblasts (TIG-
3) and fibroblasts from the two infants described in the present report
(MY1sk and PCS1), without and with 65 h of treatment with colcemid.
and analyzed by flow cytometry. Normal fibroblasts
(TIG-3) and the cells from the two infants that we have
described above (MY1sk and PCS1), without treatment
with colcemid, all showed a tall 2C peak and a small
4C peak (fig. 3, top). After treatment with colcemid, the
normal fibroblasts (TIG-3) had shifted from the DNA
content of 2C to 4C, an indication of mitotic block,
along with a 2C cell distribution that may correspond
to G0 resting cells. TIG-3 showed, in addition, a small
fraction with DNA content less than 2C, which may
represent apoptotic cells induced by colcemid. On the
other hand, MY1sk and PCS1 both exhibited the smaller
2C peak and the taller 4C peak, similar to those in TIG-
3, and a small additional peak at 8C. The accumulation
of the 8C cells provided evidence that the cells escaped
from mitotic arrest and entered the second G2/M phase
without sister-chromatid segregation and cytokinesis.
We infer that the 4C cells in MY1sk and PCS1 are not
the mitotic-blocked cells but, rather, the cells entering
G1 phase without going through sister-chromatid seg-
regation, as seen in figure 2.
In the present study, cultured fibroblasts from the two
unrelated affected infants showed total PCS with mosaic
variegated aneuploidy and did not arrest in metaphase
after treatment with colcemid. Instead, as measured by
BrdU incorporation and microscopic analysis, the cells
entered G1 and then S phases without sister-chromatid
segregation and cytokinesis. Cell-cycle studies demon-
strated the accumulation of large numbers of the infants’
cells with a DNA content of 8C. These results provide
additional evidence that the infants’ cells are insensitive
to the colcemid-induced mitotic-spindle checkpoint.
Mitotic-spindle checkpoint originally was defined
by yeast mutants that failed to arrest in mitosis when
treated with a microtubule-disrupting agent. By means
of this strategy, MAD (mitosis-arrest deficient [Li
and Murray 1991]) and BUB (budding uninhibited
by benomyl [Hoyt et al. 1991]) genes have been re-
covered, and genetic and biochemical studies show
that these products are part of a signaling cascade
that, by inactivating an anaphase-promoting complex
(APC) and its regulator protein Cdc20, blocks sister-
chromatid separation (for a review, see Gardner and
Burke 2000). Some of these proteins localize to ki-
netochores that are not attached to the mitotic spin-
dle, suggesting that the checkpoint proteins sense and
respond to the unattached kinetochore. Human coun-
terparts (hMAD1-2, hMAD2B, hBUB1-2, hBUBR1/
MAD3, hCDC20/p55CDC, and hMPS1) of the yeast
components have been cloned and shown to be re-
quired for the checkpoint control (Cahill et al. 1999;
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for reference, see Dobie et al. 1999). Low-level ex-
pression of the hMAD2 gene was found in some of
the breast cancer cells that exhibited an abnormal mi-
totic checkpoint (Li and Benezra 1996). The loss-of-
function in hMAD1 protein, which is due to seques-
tration by Tax, is responsible for transformation of
cells by T-cell leukemia virus (Jin et al. 1998). Mu-
tations of the hBUB1 gene cause checkpoint defects
in a small fraction of colorectal cancers (Cahill et al.
1998). In addition to these signaling components,
some kinetochore proteins have been proposed to be
involved in the mitotic-spindle checkpoint. Drosoph-
ila ZW10 is a kinetochore component that recruits
dynein, a microtubule motor, to the kinetochore, and
it plays a role in accurate chromosome segregation
(Starr et al. 1998). In zw10 null mutants, sister chro-
matids separate prematurely in the presence of a mi-
crotubule-disrupting agent, representing malfunction
of the mitotic-spindle checkpoint. Drosophila rough
deal (rod) mutants also exhibit anaphase defects sim-
ilar to those in zw10 mutants, suggesting that the two
proteins function in the same pathway (Scaerou et al.
1999). It remains to be seen which of these numerous
genes or related genes is responsible for the disorder
that we have described.
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